Post-streptococcal glomerulonephritis primary prevention

Post-streptococcal glomerulonephritis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Post-streptococcal glomerulonephritis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Post-streptococcal glomerulonephritis primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Post-streptococcal glomerulonephritis primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Post-streptococcal glomerulonephritis primary prevention
CDC on Post-streptococcal glomerulonephritis primary prevention
Post-streptococcal glomerulonephritis primary prevention in the news
Blogs on Post-streptococcal glomerulonephritis primary prevention
Directions to Hospitals Treating Post-streptococcal glomerulonephritis
Risk calculators and risk factors for Post-streptococcal glomerulonephritis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

Overview

There are no established measures for the primary prevention of [disease name].

OR

There are no available vaccines against [disease name].

OR

Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

OR

[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].

Primary Prevention

• There are no established measures for the primary prevention of [disease name].
• There are no available vaccines against [disease name].

OR

• Effective measures for the primary prevention of [disease name] include:
  • [Measure1]
  • [Measure2]
  • [Measure3]

OR

• [Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
  • [Strategy 1]
  • [Strategy 2]
  • [Strategy 3]